PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsMeningeal neoplasms
MeSH D008577 - meningeal neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D016543:Central nervous system neoplasms
$
Success rate
D008577: 
Meningeal neoplasms
$
Success rate
D008579:Meningioma
0 Companies
0 Drugs
Success rate
D055756:Meningeal carcinomatosis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCytarabine Cytarabine  1982-01-01   
Cytarabine Cytosar-u  1998-12-30   
MylanCytarabine Cytarabine  2011-12-13   
Rising PharmaceuticalsCytarabine Cytarabine  2011-12-13   
HospiraCytarabine Cytarabine  1990-06-04   
Hikma PharmaceuticalsCytarabine Cytarabine  1989-08-02   
Jazz PharmaceuticalsCytarabine, Daunorubicin Vyxeos (previously Vyxeos)  2018-08-23   
West-Ward PharmaceuticalCytarabine Cytarabine  1994-08-31   
Fresenius KabiCytarabine Cytarabine  2004-01-15   
Pacira BioSciencesCytarabine DepoCyte  2001-07-11 $1.353 M Q2/18-Q1/19 
Cytarabine Depocyt  1999-04-01   
Gland PharmaCytarabine Cytarabine  2019-12-23   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/1
Phase 2
0%
0/0
Phase 3
100%
3/3
Approved: 3Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Jazz Pharmaceuticals
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use